Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group

  title={Severe acute respiratory syndrome-related coronavirus: The species and its viruses – a statement of the Coronavirus Study Group},
  author={Alexander E. Gorbalenya and Susan C. Baker and Ralph S. Baric and Raoul J. de Groot and Christian Drosten and Anastasia A. Gulyaeva and Bart L. Haagmans and Chris Lauber and Andrey M. Leontovich and Benjamin W. Neuman and Dmitry D. Penzar and Stanley Perlman and Leo L. M. Poon and Dmitry V. Samborskiy and Igor A. Sidorov and Isabel Sola and John Ziebuhr},
The present outbreak of lower respiratory tract infections, including respiratory distress syndrome, is the third spillover, in only two decades, of an animal coronavirus to humans resulting in a major epidemic. Here, the Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses, which is responsible for developing the official classification of viruses and taxa naming (taxonomy) of the Coronaviridae family, assessed the novelty of the human pathogen tentatively named… 
Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV
The goal of this work is to systematically review and compare between SARS-CoV and SARS -CoV in the context of their virus incubation, originations, diagnosis and treatment methods, genomic and proteomic sequences, and pathogenic mechanisms.
Clinical, Molecular and Epidemiological Characterization of the SARS-CoV2 Virus and the Coronavirus Disease 2019 (COVID-19): A Comprehensive Literature Review
A comprehensive literature review of the SARS CoV-2 Virus and the Coronavirus Diseases 2019 (COVID-19) is conducted to offer a clear insight of the extensive literature available.
COVID-19: laboratory diagnosis for clinicians. An updating article.
COVID-19 (coronavirus disease 2019) is an infectious disease caused by the new coronavirus associated with severe acute respiratory syndrome 2 (SARS-CoV-2), which was identified in an outbreak of pneumonia cases in Wuhan city, Hubei province, China, in December 2019.
An Outbreak of a New Infectious Disease COVID-19: β-coronaviruses as a Threat to Global Healthcare
It is concluded that SARS-CoV-2 has pandemic potential and that new strains of β-coronaviruses are likely to cause outbreaks in the future.
Understanding the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence - A narrative review
It is hoped that Covid-19 prevention, control and treatment will be achieved through vaccine and antiviral agents' production as well as health care measures in the near future.
Insight into Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): Rationalized Review Special Reference to COVID-19
The genetic morphology, pathogenesis and the therapeutic intervention of SARS-CoV-2 are analyzed, and the future perspective to confront with this viral epidemic is discussed.
Understanding COVID-19 - A Molecular Perspective
An overview of the biology, transmissibility, and genome organization of SARS-CoV-2 is given and the available diagnostic, therapeutic and vaccine strategies for COVID-19 are described.
Coronavirus disease 2019 (COVID-19): Diagnosis and management
The aim is here to discuss the COVID-19 disease beginning from virology, epidemiology and continuing with clinical manifestations, diagnosis, its complications and to finish with available therapeutic options and conclusion.


Severe Acute Respiratory Syndrome Coronavirus Phylogeny: toward Consensus
SARS-CoV genome sequences have been used to define the phylogenetic position of SARSCoV among coronaviruses, and the situation from an insider’s point of view is clarified.
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Identification and characterization of a new coronavirus (2019-nCoV), which caused an epidemic of acute respiratory syndrome in humans in Wuhan, China, and it is shown that this virus belongs to the species of SARSr-CoV, indicates that the virus is related to a bat coronav virus.
Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin
The identification and characterization of a novel coronavirus (nCoV-2019) which caused an epidemic of acute respiratory syndrome in humans, in Wuhan, China, and it is confirmed that this novel CoV uses the same cell entry receptor, ACE2, as SARS-CoV.
A novel coronavirus associated with severe acute respiratory syndrome.
A novel coronavirus is associated with this outbreak of severe acute respiratory syndrome, and the evidence indicates that this virus has an etiologic role in SARS.
Identification of a novel coronavirus in patients with severe acute respiratory syndrome.
The novel coronavirus might have a role in causing SARS and was detected in a variety of clinical specimens from patients with SARS but not in controls.
Evidence of the Recombinant Origin of a Bat Severe Acute Respiratory Syndrome (SARS)-Like Coronavirus and Its Implications on the Direct Ancestor of SARS Coronavirus
Evidence of the recombinant origin of the genome of a bat SLCoV is demonstrated and a potential recombination breakpoint is identified immediately after the consensus intergenic sequence between open reading frame 1 and the S coding region, suggesting the replication intermediates may participate in the recombination event, as previously speculated for other CoVs.
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
Phylogenetic analyses and sequence comparisons showed that SARS-CoV is not closelyrelated to any of the previouslycharacterized coronaviruses.
Viral evolution and the emergence of SARS coronavirus.
  • E. Holmes, A. Rambaut
  • Biology
    Philosophical transactions of the Royal Society of London. Series B, Biological sciences
  • 2004
It is shown that the phylogenetic patterns cited as evidence for recombination are more probably caused by a variation in substitution rate among lineages and that recombination is unlikely to explain the appearance of SARS in humans.
Middle East Respiratory Syndrome.
  • D. Hui, M. Peiris
  • Medicine
    American journal of respiratory and critical care medicine
  • 2015
No specifi c drug treatment exists for MERS and infection prevention and control measures are crucial to prevent spread in health-care facilities, however, the virus could mutate to have increased interhuman transmissibility, increasing its pandemic potential.